PADI4 and Sepsis: Therefore, it can more effectively sequester CitH3 generated by both PAD2 and PAD4 as compared with the commercial CitH3 antibody bound only to the epitope of R2/R8/R17 (29), which makes it a potentially effective agent for treating sepsis-ALI in animal models.